In this video, Amrita Krishnan, MD, director of the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope Cancer Center, discusses the progress in multiple myeloma highlighted at ASCO Annual Meeting.
Krishnan specifically discusses the positive moves made in bispecific antibodies, but extensively delves into the challenges posed by the continuing COVID-19 pandemic.
“These are challenging times for us and the impact COVID has made upon our patients,” Krishnan said.
